StockData
COSCIENS Biopharma Inc. logo

COSCIENS Biopharma Inc. (CSCIF) stock

CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 20-F on Mar 25, 2026Score 1/30
$6.49+0.00 (0.00%)

Close on Oct 19, 2026Market cap $24.10MP/E –Yield –

COSCIENS Biopharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

COSCIENS Biopharma's revenue for the twelve months ending Mar 31, 2026 was $7.89M, down 11.6% year over year. For fiscal 2025 it was $7.50M, down 21.8% from the year before. Over ten years it grew 30.0% a year on average. The highest annual figure on record is $26.88M in fiscal 2018.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.50M-21.8%
FY2024Dec 31, 2024$9.59M+34.2%
FY2023Dec 31, 2023$7.14M-51.0%
FY2022Dec 31, 2022$14.57M+177.0%
FY2021Dec 31, 2021$5.26M+44.0%
FY2020Dec 31, 2020$3.65M+586.5%
FY2019Dec 31, 2019$532.00K-98.0%
FY2018Dec 31, 2018$26.88M+2812.4%
FY2017Dec 31, 2017$923.00K+1.3%
FY2016Dec 31, 2016$911.00K+67.2%
FY2015Dec 31, 2015$545.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026$1.89M+36.1%
Q4 FY2025Dec 31, 2025$1.77M-46.8%
Q3 FY2025Sep 30, 2025$1.48M-20.7%
Q2 FY2025Jun 30, 2025$2.75M+17.6%
Q1 FY2025Mar 31, 2025$1.39M-32.6%
Q4 FY2024Dec 31, 2024$3.32M+173.6%
Q3 FY2024Sep 30, 2024$1.87M-4.1%
Q2 FY2024Jun 30, 2024$2.34M+67.9%
Q1 FY2024Mar 31, 2024$2.06M-3.3%
Q4 FY2023Dec 31, 2023$1.21M-89.4%
Q3 FY2023Sep 30, 2023$1.95M+4.9%
Q2 FY2023Jun 30, 2023$1.39M–
Q1 FY2023Mar 31, 2023$2.13M+40.3%
Q4 FY2022Dec 31, 2022$11.42M+1094.2%
Q3 FY2022Sep 30, 2022$1.86M+76.8%
Q2 FY2022Jun 30, 2022-$222.00K-114.0%
Q1 FY2022Mar 31, 2022$1.52M-9.1%
Q4 FY2021Dec 31, 2021$956.00K-59.6%
Q3 FY2021Sep 30, 2021$1.05M+721.9%
Q2 FY2021Jun 30, 2021$1.58M+2229.4%
Q1 FY2021Mar 31, 2021$1.67M+53.0%
Q4 FY2020Dec 31, 2020$2.37M+13044.4%
Q3 FY2020Sep 30, 2020$128.00K-54.8%
Q2 FY2020Jun 30, 2020$68.00K-64.9%
Q1 FY2020Mar 31, 2020$1.09M+2845.9%
Q4 FY2019Dec 31, 2019$18.00K-98.7%
Q3 FY2019Sep 30, 2019$283.00K-57.3%
Q2 FY2019Jun 30, 2019$194.00K+15.5%
Q1 FY2019Mar 31, 2019$37.00K–
Q4 FY2018Dec 31, 2018$1.39M–
Q3 FY2018Sep 30, 2018$663.00K–
Q2 FY2018Jun 30, 2018$168.00K–

More COSCIENS Biopharma figures

See a number that looks wrong?